Operating EBITDA* grew by 44% to INR 202 crores Mumbai (Maharashtra) [India], November 12: JB Pharma, one of the fastest growing pharmaceutical companies in India continued on its strong growth momentum, announced its financial results for the second quarter ended 30th September 2022, registering YoY growth of 36% in Q2 FY23 and 33% in H1 […]
Breaking News
Wednesday, December 18, 2024
